Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
79.93B | 80.45B | 98.95B | 110.24B | 122.81B | Gross Profit |
62.20B | 61.40B | 72.55B | 81.06B | 93.04B | EBIT |
18.62B | 16.96B | 14.06B | 21.51B | 29.50B | EBITDA |
46.23B | 22.89B | 39.39B | 50.57B | 56.77B | Net Income Common Stockholders |
19.11B | 13.73B | 13.65B | 11.34B | 17.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
11.99B | 20.86B | 10.26B | 15.60B | 20.97B | Total Assets |
229.58B | 218.38B | 239.25B | 225.74B | 256.53B | Total Debt |
101.62B | 102.19B | 118.52B | 131.40B | 150.00B | Net Debt |
91.24B | 82.64B | 108.59B | 116.17B | 129.42B | Total Liabilities |
147.04B | 147.95B | 174.88B | 194.25B | 212.62B | Stockholders Equity |
76.62B | 64.48B | 60.13B | 26.29B | 38.32B |
Cash Flow | Free Cash Flow | |||
18.10B | 14.39B | 19.92B | 22.82B | 24.82B | Operating Cash Flow |
31.48B | 29.12B | 39.22B | 42.27B | 43.82B | Investing Cash Flow |
-11.49B | -18.30B | -23.14B | -17.23B | -10.56B | Financing Cash Flow |
-29.39B | -1.53B | -23.98B | -27.90B | -27.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $299.72B | 26.77 | 17.93% | 1.17% | 3.62% | 38.24% | |
79 Outperform | $19.25B | 11.26 | 27.97% | 4.22% | -2.32% | ― | |
76 Outperform | $202.42B | 18.54 | 10.54% | 4.01% | -0.08% | -24.48% | |
73 Outperform | $183.37B | 10.51 | 18.27% | 6.08% | 0.61% | 50.39% | |
64 Neutral | $6.48B | ― | -17.68% | ― | 32.25% | 20.56% | |
59 Neutral | $29.14B | 0.91 | -18.74% | 4.05% | 2.07% | -49.65% | |
47 Neutral | $4.27B | ― | -12.49% | ― | -9.95% | 99.47% |